Ptc Therapeutics (PTCT) Amortizatization of Intangibles (2014 - 2026)
Ptc Therapeutics' (PTCT) quarterly Amortizatization of Intangibles came in at $4.1 million in Q1 2026, up 77.86% year-on-year from $2.3 million in Q1 2025, and down 18.53% quarter-over-quarter from $5.0 million in Q4 2025.
Ptc Therapeutics (PTCT) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends
Ptc Therapeutics' Amortizatization of Intangibles history runs 13 years deep, the most recent figure standing at $4.1 million for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 77.86% year-over-year to $4.1 million in Q1 2026; TTM through Mar 2026 was $19.8 million, a 77.86% increase from a year earlier, with the FY2025 full-year figure at $18.0 million, up 43.84% from the prior year.
- Amortizatization of Intangibles retreated to $4.1 million in Q1 2026 per PTCT's latest filing, from $5.0 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $6.1 million in Q3 2025 and bottomed at -$887000.0 in Q1 2022.
- The 5-year median for Amortizatization of Intangibles is $2.3 million (2025), against an average of $2.1 million.
- Across the five-year window, Amortizatization of Intangibles jumped 295300.0% in 2024 and slumped 37.44% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $79000.0 in 2022, then jumped by 2572.15% to $2.1 million in 2023, then advanced by 22.31% to $2.6 million in 2024, then jumped by 95.58% to $5.0 million in 2025, then decreased by 18.53% to $4.1 million in 2026.
- Per Business Quant, the three latest PTCT Amortizatization of Intangibles figures stand at $4.1 million (Q1 2026), $5.0 million (Q4 2025), and $6.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Ptc Therapeutics | 6.27 Bn | 4.38 Bn | 244.52 Mn | 4.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.11 Mn |
| Mar 31, 2026 | 4.11 Mn |
| Dec 31, 2025 | 5.05 Mn |
| Dec 31, 2025 | 5.05 Mn |
| Sep 30, 2025 | 6.10 Mn |
| Sep 30, 2025 | 6.10 Mn |
| Jun 30, 2025 | 4.56 Mn |
| Jun 30, 2025 | 4.56 Mn |
| Mar 31, 2025 | 2.31 Mn |
| Mar 31, 2025 | 2.31 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Dec 31, 2024 | 2.58 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Sep 30, 2024 | 2.95 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Jun 30, 2024 | 3.30 Mn |
| Mar 31, 2024 | 3.70 Mn |
| Mar 31, 2024 | 3.70 Mn |
| Dec 31, 2023 | 2.11 Mn |
| Dec 31, 2023 | 2.11 Mn |